Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nupam P Mahajan

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Cancer Letters|April 20, 2013
ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferationKiran Mahajan, Nupam P Mahajan
Nucleic Acids Research|November 8, 2015
Cross talk of tyrosine kinases with the DNA damage signaling pathwaysKiran Mahajan, Nupam P Mahajan
Journal of Cellular Physiology|May 1, 2010
Shepherding AKT and androgen receptor by Ack1 tyrosine kinaseKiran Mahajan, Nupam P Mahajan
Journal of Cellular Physiology|February 7, 2012
PI3K-independent AKT activation in cancers: a treasure trove for novel therapeuticsKiran Mahajan, Nupam P Mahajan
Trends in Genetics : TIG|March 30, 2013
WEE1 tyrosine kinase, a novel epigenetic modifierKiran Mahajan, Nupam P Mahajan
Trends in Pharmacological Sciences|December 25, 2024
ACK1/TNK2 kinase: molecular mechanisms and emerging cancer therapeuticsDhivya Sridaran, Nupam P Mahajan
The Journal of Biological Chemistry|August 16, 2003
An SH2 domain-dependent, phosphotyrosine-independent interaction between Vav1 and the Mer receptor tyrosine kinase: a mechanism for localizing guanine nucleotide-exchange factor actionNupam P Mahajan, H Shelton Earp
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
AKT goes cyclingKiran N Mahajan, Nupam P Mahajan
Trends in Cancer|February 10, 2024
Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppressionDuminduni Hewa Angappulige, Nupam P Mahajan, Kiran Mahajan
The Journal of Biological Chemistry|October 3, 2013
Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell deathEmma Linderoth, Giulia Pilia, Nupam P Mahajan, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Cancer Letters|April 20, 2013
ACK1 tyrosine kinase: targeted inhibition to block cancer cell proliferationKiran Mahajan, Nupam P Mahajan
Nucleic Acids Research|November 8, 2015
Cross talk of tyrosine kinases with the DNA damage signaling pathwaysKiran Mahajan, Nupam P Mahajan
Journal of Cellular Physiology|May 1, 2010
Shepherding AKT and androgen receptor by Ack1 tyrosine kinaseKiran Mahajan, Nupam P Mahajan
Journal of Cellular Physiology|February 7, 2012
PI3K-independent AKT activation in cancers: a treasure trove for novel therapeuticsKiran Mahajan, Nupam P Mahajan
Trends in Genetics : TIG|March 30, 2013
WEE1 tyrosine kinase, a novel epigenetic modifierKiran Mahajan, Nupam P Mahajan
Trends in Pharmacological Sciences|December 25, 2024
ACK1/TNK2 kinase: molecular mechanisms and emerging cancer therapeuticsDhivya Sridaran, Nupam P Mahajan
The Journal of Biological Chemistry|August 16, 2003
An SH2 domain-dependent, phosphotyrosine-independent interaction between Vav1 and the Mer receptor tyrosine kinase: a mechanism for localizing guanine nucleotide-exchange factor actionNupam P Mahajan, H Shelton Earp
Cancer Control : Journal of the Moffitt Cancer Center|June 24, 2014
AKT goes cyclingKiran N Mahajan, Nupam P Mahajan
Trends in Cancer|February 10, 2024
Epigenetic underpinnings of tumor-immune dynamics in prostate cancer immune suppressionDuminduni Hewa Angappulige, Nupam P Mahajan, Kiran Mahajan
The Journal of Biological Chemistry|October 3, 2013
Activated Cdc42-associated kinase 1 (Ack1) is required for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) receptor recruitment to lipid rafts and induction of cell deathEmma Linderoth, Giulia Pilia, Nupam P Mahajan, et al.
Pageof 5